[123I]β-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration

Movement Disorders

Volumn 15, Issue 6, 2000, Pages 1158-1167

  Pirker, Walter ^a   Asenbaum, Susanne ^a   Bencsits, Gerhard ^b   Prayer, Daniela ^a   Gerschlager, Willibald ^a   Deecke, Lüder ^a   Brücke, Thomas ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b Wilhelminenspital der Stadt Wien ^*  (Austria)

Author keywords

123I CIT; Corticobasal degeneration; Dopamine transporter; Multiple system atrophy; Progressive supranuclear palsy; Single photon emission computed tomograpy

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; IODINE 123; COCAINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CAUDATE NUCLEUS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS STRIATUM; CORTICOBASAL DEGENERATION; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISABILITY; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; IMAGE ANALYSIS; ISOTOPE LABELING; ISOTOPE TRACING; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PUTAMEN; RELIABILITY; SHY DRAGER SYNDROME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BASAL GANGLION; BRAIN CORTEX; CASE CONTROL STUDY; COMPARATIVE STUDY; DEGENERATIVE DISEASE; IMAGE PROCESSING; METHODOLOGY; MIDDLE AGED; PREDICTION AND FORECASTING; SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; BASAL GANGLIA; CASE-CONTROL STUDIES; CEREBRAL CORTEX; COCAINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SUPRANUCLEAR PALSY, PROGRESSIVE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0033626002     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(200011)15:6<1158::AID-MDS1015>3.0.CO;2-0     Document Type: Article

References (38)

1. Accuracy of clinical diagnosis in parkinsonism-a prospective study
2. The accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinicopathological study
3. Multiple system atrophy
4. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski-syndrome): Report of the NINDS-SPSP international workshop
5. Update on the accuracy of clinical diagnosis of idiopathic Parkinson's disease
6. 18F-dopa uptake in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy
7. 18F-dopa PET data
8. Initial experience with single photon emission tomography using iodine-123-labelled 2β-carbomethoxy-3-β-(iodophenyl) tropane in human brain
9. 123I]β-CIT. Binding kinetics in the human brain
10. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporter in Parkinson disease
11. 123I]β-CIT-SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease
12. 123I]β-CIT striatal uptake correlates with symptom severity in Parkinson's disease
13. 123I]β-CIT SPECT
14. Imaging of dopamine transporters with iodine-123-β-CIT and SPECT in Parkinson's disease
15. 123I]β-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy
16. 123I]-2β-Carbomethoxy-3-β-(iodophenyl) tropane: High-affinity SPECT radiotracer of monoamine reuptake sites in the brain
17. Accuracy of the clinical diagnosis of corticobasal degeneration: A clinicopathologic study
18. Unified Parkinson's disease rating scale
19. Parkinsonism: Onset, progression and mortality
20. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease
21. 3H]paroxetine binding to serotonin uptake sites in human brain tissue
22. 3H]GBR-12935 binding to dopamine uptake sites in the human brain
23. 123I]β-CIT binding to dopamine transporters in healthy human subjects
24. 125I]RTI-55: A potent ligand for dopamine transporters
25. 123I]β-CIT: Pharmacological characterization of brain uptake in non-human primates
26. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET
27. Central dopaminergic pathways in hemiparkinsonism examined by positron emission tomography
28. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease
29. Progressive supranuclear palsy: Relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers
30. Dopaminergic and cholinergic lesions in progressive supranuclear palsy
31. Subdivisional involvement of nigrostriatal loop in idiopathic Parkinson's disease and striatonigral degeneration
32. 123I]β-CIT in Parkinson's disease and progressive supranuclear palsy, evaluated with single-photon emission tomography
33. 123I]β-CIT: Pharmacological characterization of brain uptake in non-human primates
34. 123I]β-CIT
35. β-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo
36. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease
37. 123I-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism
38. Dopamine D2 receptor imaging and measurement with SPECT